- Home
- SKIN vs CBUS Comparison
SKIN vs CBUS Comparison
Compare SKIN & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKIN | CBUS |
|---|---|---|
| Founded | 1997 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Agricultural Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.4M | 98.5M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | SKIN | CBUS |
|---|---|---|
| Price | $0.73 | $1.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $2.03 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 4.9M | 449.6K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 55.56 | ★ 74.33 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $300,790,000.00 | $3,639,000.00 |
| Revenue This Year | $0.88 | $112.72 |
| Revenue Next Year | $4.60 | $83.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.55 | $1.09 |
| 52 Week High | $2.69 | $4.19 |
Technical Indicators
Market Signals| Indicator | SKIN | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 56.93 |
| Support Level | N/A | $1.56 |
| Resistance Level | N/A | $2.49 |
| Average True Range (ATR) | 0.00 | 0.16 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 64.44 |
Price Performance
Historical ComparisonAbout SKIN The Beauty Health Company
SkinHealth Systems Inc is a world-wide medical aesthetics company delivering an integrated ecosystem of clinically validated solutions designed to help consumers achieve superior skin health and support the success of providers. Its brands are Hydrafacial and SkinStylus.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.